Activity of the pyrazoloacridines against multidrug-resistant tumor cells

Cancer Chemotherapy and Pharmacology

Volumn 24, Issue 4, 1989, Pages 219-224

  Sebolt, Judith ^a   Havlick, Martha ^a   Hamelehle, Katherine ^a   Nelson, James ^a   Leopold, Wilbur ^a   Jackson, Robert ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PYRAZOLO[3,4,5 KL]ACRIDINE DERIVATIVE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; CANCER CHEMOTHERAPY; CELL CULTURE; DRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ACRIDINES; ADENOCARCINOMA; ANIMAL; ANTINEOPLASTIC AGENTS; CELL LINE; COMPARATIVE STUDY; DOXORUBICIN; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; INTERCALATING AGENTS; LEUKEMIA P388; LEUKEMIA, EXPERIMENTAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; PYRAZOLES; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VINCRISTINE;

EID: 0024381930     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00257621     Document Type: Article

References (22)

1. 2-Aminoalkyl-5-nitropyrazolo [3,4,5-kl]acridines, a new class of anticancer agents
2. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and-resistant P388 murine leukemia cells
3. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy
4. A semiatomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells
5. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia
6. Biochemical and experimental chemotherapy studies of the pyrazoloacridines
7. In vivo characteristics of resistance and cross-resistance of an Adriamycin-resistant subline of P388 leukemia
8. Experimental antitumor activity of aminoanthraquinones
9. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists
10. Correlation between in vitro and in vivo testing of DNA-binders versus antifolates in multiple-drug resistant (MDR) P388 cells (P388R)
11. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive propertics
12. Biological and biochemical properties of the 2-aminoalkyl-5-nitropyrazolo [3,4,5-k]acridines (pyrazoloacridines)
13. Quantitative evaluation of anticancer activity in experimental animals
14. Establishment of cross-resistance profiles for new agents
15. Establishment of Adriamycin-resistant mammary adenocarcinoma 16/C in vitro and its sensitivity to the anthrapyrazoles CI-942 and CI-937
16. Solid tumor selectivity of the 2-aminoalkyl-5-nitropyrazrolo [3,4,5-kl]acridines, a novel class of DNA-binding antitumor agents
17. Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
18. Reversal of resistance to anthracyclines by aclacinomycin A
19. Enhancement of vincristine-and Adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and Adriamycin
20. New anticancer agents
21. A phase II study of aclacinomycin A in acute leukemia in adults